No Data
No Data
No Data
No Data
No Data
Verastem Names John Hayslip as Chief Medical Officer
Verastem (VSTM) said late Thursday it appointed John Hayslip as chief medical officer, succeeding Louis Denis, who recently left the company. Hayslip most recently served as the chief medical officer
MT NewswiresApr 18 17:36 ET
I-Mab Announces CMO Transition, Interim Successor Named
TipRanksApr 15 21:03 ET
I-MAB Buy Rating Justified by Strong Leadership and Promising Pipeline
TipRanksApr 12 06:08 ET
Express News | Needham Reiterates Buy on I-MAB, Maintains $6 Price Target
Moomoo 24/7Apr 12 06:04 ET
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
ROCKVILLE, Md., April 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiate
I-Mab BiopharmaApr 5 00:00 ET
I-Mab Finalizes Divestiture and Resolves Obligations
TipRanksApr 2 17:59 ET
No Data
No Data